Evidence map›Paper›PMID 25127994›Full record

ArticleDevelopmental biology2014

Sterol carrier protein 2 regulates proximal tubule size in the Xenopus pronephric kidney by modulating lipid rafts.

Débora M Cerqueira, Uyen Tran, Daniel Romaker, José G Abreu, Oliver Wessely

Open access · greenAbstract read
In one paragraph

Article in Developmental biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Modulating Ca²⁺ signals: a common theme for TMEM16, Ist2, and TMC.Pflugers Archiv : European journal of physiology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Débora M CerqueiraCleveland Clinic Foundation, Lerner Research Institute, Department Cellular and Molecular Medicine, 9500 Euclid Avenue/NC10 Cleveland, OH 44195, USA; Universidade Federal do Rio de Janeiro, Instituto de Ciências Biomédicas-CCS, Av. Carlos Chagas Filho, 373 bloco F2 sala 15, Rio de Janeiro 21949-590, Brazil.
Uyen TranCleveland Clinic Foundation, Lerner Research Institute, Department Cellular and Molecular Medicine, 9500 Euclid Avenue/NC10 Cleveland, OH 44195, USA.
Daniel RomakerCleveland Clinic Foundation, Lerner Research Institute, Department Cellular and Molecular Medicine, 9500 Euclid Avenue/NC10 Cleveland, OH 44195, USA.
José G AbreuUniversidade Federal do Rio de Janeiro, Instituto de Ciências Biomédicas-CCS, Av. Carlos Chagas Filho, 373 bloco F2 sala 15, Rio de Janeiro 21949-590, Brazil.
Oliver WesselyCleveland Clinic Foundation, Lerner Research Institute, Department Cellular and Molecular Medicine, 9500 Euclid Avenue/NC10 Cleveland, OH 44195, USA. Electronic address: wesselo@ccf.org.
Cleveland Clinic · USUniversidade Federal do Rio de Janeiro · BR

Funding

The Role of Bicaudal-C in Polycystic Kidney DiseaseR01DK080745 · NIDDK · LSU HEALTH SCIENCES CENTER · PI WESSELY, OLIVER · 2009 to 2013
$1.7M
NIDDK NIH HHS 5R01DK080745-05NIDDK NIH HHS R01 DK080745
6 · The paper itself

Abstract

The kidney is a homeostatic organ required for waste excretion and reabsorption of water, salts and other macromolecules. To this end, a complex series of developmental steps ensures the formation of a correctly patterned and properly proportioned organ. While previous studies have mainly focused on the individual signaling pathways, the formation of higher order receptor complexes in lipid rafts is an equally important aspect. These membrane platforms are characterized by differences in local lipid and protein compositions. Indeed, the cells in the Xenopus pronephric kidney were positive for the lipid raft markers ganglioside GM1 and Caveolin-1. To specifically interfere with lipid raft function in vivo, we focused on the Sterol Carrier Protein 2 (scp2), a multifunctional protein that is an important player in remodeling lipid raft composition. In Xenopus, scp2 mRNA was strongly expressed in differentiated epithelial structures of the pronephric kidney. Knockdown of scp2 did not interfere with the patterning of the kidney along its proximo-distal axis, but dramatically decreased the size of the kidney, in particular the proximal tubules. This phenotype was accompanied by a reduction of lipid rafts, but was independent of the peroxisomal or transcriptional activities of scp2. Finally, disrupting lipid micro-domains by inhibiting cholesterol synthesis using Mevinolin phenocopied the defects seen in scp2 morphants. Together these data underscore the importance for localized signaling platforms in the proper formation of the Xenopus kidney.

Indexed as

AnimalsAnticholesteremic AgentsBody PatterningCarrier ProteinsCell LineCholesterolGene Knockdown TechniquesHEK293 CellsHumansKidney Tubules, ProximalLovastatinMembrane MicrodomainsMorpholinosRNA, MessengerTranscription, GeneticXenopus laevisAnticholesteremic AgentsCarrier ProteinsCholesterolLovastatinMorpholinosRNA, Messengersterol carrier proteinsXenopus ProteinsCholesterolLipid raftsOrgan size controlPronephrosSterol carrier protein 2Xenopus

Identifiers

PMID25127994
PMCPMC4163507
OpenAlexW1965908592

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.